A.L. Elizarova

А.Л. Елизарова

8 articles 2011–2024

2024

Possibilities of using parnaparin sodium in oncology Technologies of Living Systems, No. 3, 2024 pp. 45-52

2020

Genetic predisposition in the formation of the risk of thromboembolism in cancer patients Achievements of Modern Radioelectronics, No. 1, 2020 pp. 5-14
Genetic predisposition in the formation of the risk of thromboembolism in cancer patients Technologies of Living Systems, No. 1, 2020 pp. 5-14

2019

Thrombotic complications in patients with kidney cancer and their prevention Technologies of Living Systems, No. 4, 2019 pp. 5-15

2014

Low molecular weight heparins for the prevention and therapy thrombotic complication in oncological patients Вопросы биологической, медицинской и фармацевтической химии, No. 8, 2014 pp. 59-64

2013

Abnormalities of hemostasis and vte in cancer patients Technologies of Living Systems, No. 3, 2013 pp. 70-78

2012

Prevention of abnormalities of hemostasis and vte in ovarian cancer patients, undergoing chemotherapy Technologies of Living Systems, No. 9, 2012 pp. 43-47

2011

Abnormalities of Haemostasis in Cancer Patients with Thrombosis and Thromboembolic of Pulmonary Artery, which Occurred During Subacute Disseminated Intravascular Coagulation Technologies of Living Systems, No. 7, 2011 pp. 34-39